Cargando…
Use of Filgrastim (r-metHuG-CSF) in Human Immunodeficiency Virus Infection
In 2008, an estimated 33.4 million individuals worldwide were infected with the human immunodeficiency virus (HIV) [1]. Only a few years ago, infection with HIV almost invariably culminated in the development of the acquired immunodeficiency syndrome (AIDS), characterized by severe depletion of CD4(...
Autores principales: | Hemmige, Vagish, Liles, W. Conrad, Pitrak, David L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7123730/ http://dx.doi.org/10.1007/978-3-0348-0218-5_18 |
Ejemplares similares
-
Filgrastim (r-metHuG-CSF) in clinical practice. Basic and clinical oncology series/5
por: Crowther, D.
Publicado: (1994) -
Long-term safety of filgrastim (rhG-CSF) administration
por: Confer, Dennis L, et al.
Publicado: (2007) -
Biomarker Supervised G-CSF (Filgrastim) Response in ALS Patients
por: Johannesen, Siw, et al.
Publicado: (2018) -
Differential role of r-met-hu G-CSF on male reproductive function and development in prepubertal domestic mammals
por: Aponte, Pedro M., et al.
Publicado: (2019) -
Filgrastim (G-CSF) loaded liposomes: mathematical modeling and optimization of encapsulation efficiency and particle size
por: Kiafar, Farhad, et al.
Publicado: (2016)